Drug Shortage Report for GLN-OLMESARTAN HCTZ

Last updated on 2026-03-17

History

Report ID	242247
Drug Identification Number	02475723
Brand name	GLN-OLMESARTAN HCTZ
Common or Proper name	OLMESARTAN HCTZ
Company Name	GLENMARK PHARMACEUTICALS CANADA INC.
Market Status	MARKETED
Active Ingredient(s)	HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s)	25MG 40MG
Dosage form(s)	TABLET
Route of administration	ORAL
Packaging size	30 tablets
Anatomical Therapeutical Chemical (ATC) code	C09DA
Anatomical Therapeutical Chemical (ATC) description	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage	Demand increase for the drug.
Anticipated start date	2025-11-01
Actual start date	2025-11-01
Estimated end date	2026-03-14
Actual end date
Shortage status	Actual shortage
Updated date	2026-03-17
Company comments	Product is on backorder
Health Canada comments
Tier 3 Status	No
Contact Address	1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 30